Evidence map›Paper›PMID 37794811›Full record

ArticleHaematologica2024

BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study.

Francesco Malfona, Ilaria Tanasi, Matteo Piccini, Cristina Papayannidis, Vincenzo Federico, Valentina Mancini, Elisa Roncoroni, Elisabetta Todisco, Simona Bianchi, Giulia Ciotti and 14 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Notch Inhibitors and BH3 Mimetics in T-Cell Acute Lymphoblastic Leukemia.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Francesco MalfonaHematology, Department of Translational and Precision Medicine, Sapienza University.
Ilaria TanasiDepartment of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona.
Matteo PicciniSOD Ematologia, Università Di Firenze, AOU Careggi, Firenze.
Cristina PapayannidisIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna.
Vincenzo FedericoHematology and Transplant Unit, Vito Fazzi Hospital, Lecce.
Valentina ManciniASST Grande Ospedale Metropolitano Niguarda, Milano.
Elisa RoncoroniDivision of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia.
Elisabetta TodiscoIEO, European Institute of Oncology IRCCS, Milan.
Simona BianchiHematology, Department of Translational and Precision Medicine, Sapienza University.
Giulia CiottiOnco Hematology, Department of Oncology-Veneto Institute of Oncology IOV-IRCCS, Padua.
Patrizia ChiusoloSezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore.
Massimo GentileHematology Unit AO of Cosenza, Cosenza, Italy; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende.
Valentina GianfeliciDepartment Hematology-Oncology- Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro.
Fabio GiglioHaematology and BMT Unit, IRCCS San Raffaele Scientific Institute, Milan.
Michele MalagolaBlood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, "ASST-Spedali Civili" Hospital of Brescia, Department of Clinical and Experimental Sciences, University of Brescia, Brescia.
Antonino MuléDivision of Onco-Hematology, AO Ospedali Riuniti Villa Sofia-Cervello, Palermo.
Francesco SaraceniHematology and Stem Cell Transplant, Ancona University Hospital.
Calogero VetroHematology and BMT Unit, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico-San Marco", Catania.
Francesco ZallioHematology Department, SS Antonio and Biagio and C. Arrigo Hospital, Alessandria.
Luca Vincenzo CappelliHematology, Department of Translational and Precision Medicine, Sapienza University.
Giovanni PizzoloDepartment of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona.
Robin FoàHematology, Department of Translational and Precision Medicine, Sapienza University.
Massimiliano BonifacioDepartment of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona.
Sabina ChiarettiHematology, Department of Translational and Precision Medicine, Sapienza University. chiaretti@bce.uniroma1.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Precursor Cell Lymphoblastic Leukemia-LymphomaAcute DiseaseAdultHumans

Identifiers

PMID37794811
PMCPMC10905092

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.